Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responses
about
Personalised medicine for multiple sclerosis care.Personalized medicine in rheumatology: the paradigm of serum autoantibodies.Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind studPersistence of Disease-Associated Anti-Citrullinated Protein Antibody-Expressing Memory B Cells in Rheumatoid Arthritis in Clinical Remission.[Treat to target and personalized medicine (precision medicine)].
P2860
Rheumatoid arthritis clinical benefits from abatacept, cytokine blockers, and rituximab are all linked to modulation of memory B cell responses
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Rheumatoid arthritis clinical ...... ion of memory B cell responses
@en
Rheumatoid arthritis clinical ...... ion of memory B cell responses
@nl
type
label
Rheumatoid arthritis clinical ...... ion of memory B cell responses
@en
Rheumatoid arthritis clinical ...... ion of memory B cell responses
@nl
prefLabel
Rheumatoid arthritis clinical ...... ion of memory B cell responses
@en
Rheumatoid arthritis clinical ...... ion of memory B cell responses
@nl
P2860
P356
P1476
Rheumatoid arthritis clinical ...... ion of memory B cell responses
@en
P2093
Adam Pelzek
P2860
P304
P356
10.3899/JRHEUM.140022
P407
P577
2014-04-01T00:00:00Z